Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study.

about

Comments on the article "Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study"

P2860

Q58694880-3275ECDA-16FD-4C7A-8F39-A5A2A16D5F0D

P2860

Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study.

Item

http://www.wikidata.org/entity/Q52642347

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study.

@en

Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study.

@nl

type

Item

label

Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study.

@en

Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study.

@nl

prefLabel

Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study.

@en

Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study.

@nl

P1476

Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study.

@en

P2093

Cristiano Soares de Moura

http://www.w3.org/2001/XMLSchema#string

Jeffrey R Curtis

http://www.w3.org/2001/XMLSchema#string

Marina Amaral de Ávila Machado

http://www.w3.org/2001/XMLSchema#string

Sasha Bernatsky

http://www.w3.org/2001/XMLSchema#string

Steve Ferreira Guerra

http://www.w3.org/2001/XMLSchema#string

P2860

Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studies

Data-driven identification of co-morbidities associated with rheumatoid arthritis in a large US health plan claims database

Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies.

Evaluation of Real-World Experience with Tofacitinib Compared with Adalimumab, Etanercept, and Abatacept in RA Patients with 1 Previous Biologic DMARD: Data from a U.S. Administrative Claims Database.

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.

Herpes zoster and tofacitinib therapy in patients with rheumatoid arthritis.

The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents

Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritis.

Risk of hospitalized bacterial infections associated with biologic treatment among US veterans with rheumatoid arthritis.

Long-term use of biologic agents does not increase the risk of serious infections in elderly patients with rheumatoid arthritis.

P2888

s13075-018-1539-6

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13075-018-1539-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michal Abrahamowicz

P577

2018-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101695576

http://www.w3.org/2001/XMLSchema#string

P698

29566769

http://www.w3.org/2001/XMLSchema#string

P932

5865387

http://www.w3.org/2001/XMLSchema#string

Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study.

about

P2860

P2860

Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932